Teva and Samsung-Bioepis Launch Rare Disease Biosimilar in the U.S.

Viasat Advances Multi-Orbit Services ...

Momentum continues to build across Onex businesses Momentum continues to build across Onex businesses ...

GRAND CAYMAN, Cayman Islands, April 07, 2025 ( GLOBE NEWSWIRE ) -- Oxbridge Re Holdings Limited ( Nasdaq: OXBR ) ( "Oxbridge Re" ) , together with its subsidiary SurancePlus, is engaged in the tokenization of Real-World Assets ( "RWAs" ) , initially with tokenized reinsurance securities and in ...

EPYSQLI® ( eculizumab-aagh ) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized myasthenia gravis in adults who are anti-acetylcholine receptor antibody positive

CHARLESTOWN, Mass., April 07, 2025 ( GLOBE NEWSWIRE ) -- Solid Biosciences Inc. ( Nasdaq: SLDB ) ( the "Company" or "Solid" ) , a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor ...

DUBLIN, Ohio, April 07, 2025 ( GLOBE NEWSWIRE ) -- reAlpha Tech Corp. ( Nasdaq: AIRE ) ( the "Company" or "reAlpha" ) , a real estate technology company developing and commercializing artificial intelligence ( "AI" ) technologies, today announced the entry into definitive agreements for the ...

OTTAWA, Ontario, April 07, 2025 ( GLOBE NEWSWIRE ) -- Telesat ( Nasdaq and TSX: TSAT ) , one of the world's largest and most innovative satellite operators, today announced that Viasat Inc. has signed a substantial multi-year contract for Telesat Lightspeed Low Earth Orbit ( LEO ) services.

STMicroelectronics Announces Status ofCommon Share Repurchase Program ...

VELDHOVEN, the Netherlands - ASML Holding N.V. ( ASML ) reports the following transactions, conducted under ASML's current share buyback program. ASML's current share buyback program was announced on 10 November 2022, and details are available on our website at ...